<DOC>
	<DOCNO>NCT00325689</DOCNO>
	<brief_summary>A Multicenter , Double-blind 16 Week Study augmentation atypical antipsychotic Aripiprazole patient Schizophrenia inadequate response antipsychotic treatment .</brief_summary>
	<brief_title>Aripiprazole Used Dual Therapy Treatement Patients With Chronic Stable Schizophrenia Schizoaffective Disorder .</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Patient diagnosis chronic Schizophrenia Schizoaffective disorder Stable symptom dose Quetiapine Risperidone First diagnosis past year Significant risk suicide meet DSMIVTR criterion substance abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>